SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-027984
Filing Date
2019-08-01
Accepted
2019-08-01 16:25:27
Documents
52
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlo-10q_20190630.htm 10-Q 2333608
2 EX-10.4 mnlo-ex104_116.htm EX-10.4 72194
3 EX-31.1 mnlo-ex311_7.htm EX-31.1 17392
4 EX-31.2 mnlo-ex312_6.htm EX-31.2 18426
5 EX-32.1 mnlo-ex321_8.htm EX-32.1 14002
  Complete submission text file 0001564590-19-027984.txt   6751731

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnlo-20190630.xml EX-101.INS 1424657
7 XBRL TAXONOMY EXTENSION SCHEMA mnlo-20190630.xsd EX-101.SCH 34950
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnlo-20190630_cal.xml EX-101.CAL 41135
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnlo-20190630_def.xml EX-101.DEF 109872
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnlo-20190630_lab.xml EX-101.LAB 309277
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnlo-20190630_pre.xml EX-101.PRE 225100
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 19993055
SIC: 2834 Pharmaceutical Preparations